BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 12518003)

  • 1. Participation in screening for colorectal cancer based on a faecal occult blood test is improved by endorsement by the primary care practitioner.
    Cole SR; Young GP; Byrne D; Guy JR; Morcom J
    J Med Screen; 2002; 9(4):147-52. PubMed ID: 12518003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endorsement by the primary care practitioner consistently improves participation in screening for colorectal cancer: a longitudinal analysis.
    Zajac IT; Whibley AH; Cole SR; Byrne D; Guy J; Morcom J; Young GP
    J Med Screen; 2010; 17(1):19-24. PubMed ID: 20356941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
    Van Roosbroeck S; Hoeck S; Van Hal G
    Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community.
    Hughes K; Leggett B; Del Mar C; Croese J; Fairley S; Masson J; Aitken J; Clavarino A; Janda M; Stanton WR; Tong S; Newman B
    Aust N Z J Public Health; 2005 Aug; 29(4):358-64. PubMed ID: 16222934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a Doctor's Invitation on Participation in Colorectal Cancer Screening: A Cluster Randomized Trial.
    Barthe J; Perrodeau E; Gilberg S; Ravaud P; Ghasarossian C; Marchand-Buttin F; Deyra J; Falcoff H
    Am J Med; 2015 Sep; 128(9):1024.e1-7. PubMed ID: 25908395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
    Tong S; Hughes K; Oldenburg B; Del Mar C
    Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An advance notification letter increases participation in colorectal cancer screening.
    Cole SR; Smith A; Wilson C; Turnbull D; Esterman A; Young GP
    J Med Screen; 2007; 14(2):73-5. PubMed ID: 17626705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tailored telephone counselling to increase participation of underusers in a population-based colorectal cancer-screening programme with faecal occult blood test: A randomized controlled trial.
    Denis B; Broc G; Sauleau EA; Gendre I; Gana K; Perrin P
    Rev Epidemiol Sante Publique; 2017 Feb; 65(1):17-28. PubMed ID: 28089385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.
    Senore C; Armaroli P; Silvani M; Andreoni B; Bisanti L; Marai L; Castiglione G; Grazzini G; Taddei S; Gasperoni S; Giuliani O; Malfitana G; Marutti A; Genta G; Segnan N
    Am J Gastroenterol; 2010 Jan; 105(1):188-98. PubMed ID: 19826409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal occult blood screening: knowledge, attitudes, and practice in four Hong Kong primary care clinics.
    Tam TK; Ng KK; Lau CM; Lai TC; Lai WY; Tsang LC
    Hong Kong Med J; 2011 Oct; 17(5):350-7. PubMed ID: 21979470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer.
    Cole SR; Young GP; Esterman A; Cadd B; Morcom J
    J Med Screen; 2003; 10(3):117-22. PubMed ID: 14561262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of personalised decision support delivered via the internet for bowel cancer screening with a faecal occult blood test: the effects of tailoring of messages according to social cognitive variables on participation.
    Wilson CJ; Flight IH; Turnbull D; Gregory T; Cole SR; Young GP; Zajac IT
    BMC Med Inform Decis Mak; 2015 Apr; 15():25. PubMed ID: 25886492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effectiveness of GP endorsement on increasing participation in the NHS Bowel Cancer Screening Programme in England: study protocol for a randomized controlled trial.
    Damery S; Smith S; Clements A; Holder R; Nichols L; Draper H; Clifford S; Parker L; Hobbs R; Wilson S
    Trials; 2012 Feb; 13():18. PubMed ID: 22348399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for delivery of faecal occult blood test kits and participation to colorectal cancer screening in the Emilia-Romagna Region of Italy.
    Mancini S; Ravaioli A; Falcini F; Giuliani O; Corradini R; De Girolamo G; Goldoni CA; Finarelli AC; Naldoni C; Landi P; Sassoli de Bianchi P; Bucchi L
    Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28032381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uptake of faecal occult blood test colorectal cancer screening by different ethnic groups in the Netherlands.
    Deutekom M; van Rijn AF; Dekker E; Blaauwgeers H; Stronks K; Fockens P; Essink-Bot ML
    Eur J Public Health; 2009 Aug; 19(4):400-2. PubMed ID: 19372193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dietary restriction on participation in faecal occult blood test screening for colorectal cancer.
    Cole SR; Young GP
    Med J Aust; 2001 Aug; 175(4):195-8. PubMed ID: 11587278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the effectiveness of a general practice intervention to improve uptake of colorectal cancer screening: a randomised controlled trial.
    Dodd N; Carey M; Mansfield E; Oldmeadow C; Evans TJ
    Aust N Z J Public Health; 2019 Oct; 43(5):464-469. PubMed ID: 31268211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer screening using the faecal occult blood test (FOBt): a survey of GP attitudes and practices in the UK.
    Damery S; Clifford S; Wilson S
    BMC Fam Pract; 2010 Mar; 11():20. PubMed ID: 20214769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.